Published January 5, 2026 | Version v1

GeoMx Human Whole Transcriptome Atlas profiling on at-risk MASH F3 patients

  • 1. ROR icon KU Leuven

Description

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis

GeoMx Human Whole Transcriptome Atlas profiling (Bruker Spatial Biology) was performed on a cohort of eight Formalin-Fixed Paraffin-Embedded  biopsies from ‘at-risk’ MASH fibrosis stage F3 patients. Patients were classified as ‘at risk’ MASH if they have a MASH combined with a fibrosis stage of at least 2 and a MASLD Activity Score ≥4 (MAS; this is the sum of the histological scores for steatosis, hepatocyte ballooning and lobular inflammation). Regions were selected based on specific histopathological criteria and  fluorescent markers were employed to segment different macrophage (CD68), immune cell (CD45), and epithelial (Pan-keratin (panCK)) cell populations in a sequential manner. Whole Transcriptome Atlas RNA profiling was performed on a total of 80 segments. Information on regions of interest can be found in the annotation file and images. A minimum of 200 nucleated cells were recommended per region of interest to process for segmentation.

Files

raw_DCC_Files.zip

Files (1.9 GB)

Name Size
md5:79146a2f3f10801fdac79c8b647c41bb
12.1 kB Download
md5:d07bb9216eb6679ee939d54f59d878bc
7.1 MB Preview Download
md5:382539c2c5b1c88cf4bf2e70775696f0
535.2 MB Preview Download
md5:36059ee19497a8d3d9c508add5d424aa
465.8 MB Preview Download
md5:72830f72520d4b8c09687c76ca112961
431.6 MB Preview Download
md5:a8658d15a91f2fe34bee758c4e518c7e
442.8 MB Preview Download

Additional details

Related works

Is published in
Journal article: NG-A66057 (Other)

Funding

European Commission
LITMUS - Liver Investigation: Testing Marker Utility in Steatohepatitis 777377
Research Foundation - Flanders
Elucidating Macrophage Heterogeneity and Immunometabolism in Non-alcoholic Fatty Liver Disease G032324N

Dates

Accepted
2025-01-05
publication